Category: biotech

.Merck &amp Co. has actually gotten possibilities on two Evaxion Biotech vaccination applicants, paying out $3.2 thousand and also dangling much more than $1 billion

.Merck &amp Co.’s long-running attempt to land a hit on small cell lung cancer (SCLC) has acquired a tiny success. The drugmaker’s Daiichi Sankyo-partnered antibody-drug

.A phase 3 trial of Daiichi Sankyo and also Merck &amp Co.’s HER3-directed antibody-drug conjugate (ADC) has reached its primary endpoint, boosting strategies to take

.Gilead Sciences and Merck &amp Co. have actually directed their once-weekly HIV combo therapy past an additional landmark, connecting the drink to continual suppression of

.MBX has elaborated strategies to take in over $136 thousand coming from its own IPO as the biotech looks to take a potential challenger to

.MBX Biosciences has actually included in the current spurt of IPO filings. The biotech, which submitted its documentation full weeks after elevating $63.5 million independently,

.Observing a poor showing for Lykos Therapeutics’ MDMA candidate for post-traumatic stress disorder at a current FDA advisory board meeting, the various other shoe has

.Psychopharmacology has actually drawn 3 articles about midstage professional trial data analyzing Lykos Therapies’ investigational MDMA candidate for handling trauma (PTSD). The journal mentioned “sneaky

.Lykos Therapeutics might possess dropped three-quarters of its workers following the FDA’s denial of its MDMA candidate for post-traumatic stress disorder, however the biotech’s brand-new

.Lundbeck is actually reducing guide worth of its $250 thousand Abide Therapies buyout in reaction to period 1 record that caused a very early end